Multiple myeloma (MM) is a type of blood cancer that typically has no cure. Treatments like medications and stem cell ...

A Boulder woman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...

Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...

During a Case-Based Roundtable® event, Samer A. Al'Hadidi, MD, MS, discussed the CARTITUDE-4 trial of cilta-cel in patients with relapsed/refractory multiple myeloma in the first article of a 2-part ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

Teclistamab produced “clinically meaningful” responses in patients with heavily pretreated multiple myeloma who had received prior anti-BCMA treatment, according to researchers.

Researchers sought to determine whether fixed-duration therapy would still be feasible for patients with RRMM who were treated with a bispecific antibody in clinical trials and discontinued.

CAR T-cell therapy carried a risk of second primary malignancy (SPM) that was no worse than that of other standard-of-care ...

A 75-year-old woman with rheumatoid arthritis and multiple myeloma was admitted to the hospital with abdominal pain. She had ...

Patti Scialfa, the longtime wife of rock-’n’-roll superstar Bruce Springsteen and a member of his E Street Band, is dealing with multiple myeloma, reports say. Variety reports Scialfa, 71, revealed in ...

Filgotinib maleate is under clinical development by Alfasigma and currently in Phase II for Immunoglobulin G4-Related Disease (IgG4-RD). According to GlobalData, Phase II drugs for Immunoglobulin ...

It’s possible to live for many years following a relapse of multiple myeloma. Your outlook depends on a number of factors, including the length of time since your last relapse and which ...